LINEAGE THERAP earnings per share and revenue

LCTX earnings per share for the last quarter are -0.07 ILS whereas the estimation was -0.11 ILS which accounts for 33.33% surprise. Company revenue for the same period amounts to 10.57 M ILS despite the estimated figure of 5.91 M ILS. Estimated earnings per share for the next quarter are -0.09 ILS, and revenue is expected to reach 6.33 M ILS. Also watch annual changes over time to get a bigger picture of LCTX earnings per share and revenue dynamics.